Literature DB >> 21289609

Rheumatoid arthritis in 2010: from the gut to the joint.

Clemens Scheinecker1, Josef S Smolen.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 21289609     DOI： 10.1038/nrrheum.2010.226

Source DB:  PubMed          Journal:  Nat Rev Rheumatol        ISSN： 1759-4790            Impact factor:   20.543


× No keyword cloud information.
  10 in total

1.  An oral Syk kinase inhibitor in the treatment of rheumatoid arthritis: a three-month randomized, placebo-controlled, phase II study in patients with active rheumatoid arthritis that did not respond to biologic agents.

Authors:  Mark C Genovese; Arthur Kavanaugh; Michael E Weinblatt; Charles Peterfy; Julie DiCarlo; Michael L White; Maryann O'Brien; Elliott B Grossbard; Daniel B Magilavy
Journal:  Arthritis Rheum       Date:  2011-02

2.  2010 rheumatoid arthritis classification criteria: an American College of Rheumatology/European League Against Rheumatism collaborative initiative.

Authors:  Daniel Aletaha; Tuhina Neogi; Alan J Silman; Julia Funovits; David T Felson; Clifton O Bingham; Neal S Birnbaum; Gerd R Burmester; Vivian P Bykerk; Marc D Cohen; Bernard Combe; Karen H Costenbader; Maxime Dougados; Paul Emery; Gianfranco Ferraccioli; Johanna M W Hazes; Kathryn Hobbs; Tom W J Huizinga; Arthur Kavanaugh; Jonathan Kay; Tore K Kvien; Timothy Laing; Philip Mease; Henri A Ménard; Larry W Moreland; Raymond L Naden; Theodore Pincus; Josef S Smolen; Ewa Stanislawska-Biernat; Deborah Symmons; Paul P Tak; Katherine S Upchurch; Jirí Vencovsky; Frederick Wolfe; Gillian Hawker
Journal:  Ann Rheum Dis       Date:  2010-09       Impact factor: 19.103

3.  Peptidylarginine deiminase from Porphyromonas gingivalis citrullinates human fibrinogen and α-enolase: implications for autoimmunity in rheumatoid arthritis.

Authors:  Natalia Wegner; Robin Wait; Aneta Sroka; Sigrun Eick; Ky-Anh Nguyen; Karin Lundberg; Andrew Kinloch; Shauna Culshaw; Jan Potempa; Patrick J Venables
Journal:  Arthritis Rheum       Date:  2010-09

4.  An oral spleen tyrosine kinase (Syk) inhibitor for rheumatoid arthritis.

Authors:  Michael E Weinblatt; Arthur Kavanaugh; Mark C Genovese; Theresa K Musser; Elliott B Grossbard; Daniel B Magilavy
Journal:  N Engl J Med       Date:  2010-09-22       Impact factor: 91.245

5.  2010 Rheumatoid arthritis classification criteria: an American College of Rheumatology/European League Against Rheumatism collaborative initiative.

Authors:  Daniel Aletaha; Tuhina Neogi; Alan J Silman; Julia Funovits; David T Felson; Clifton O Bingham; Neal S Birnbaum; Gerd R Burmester; Vivian P Bykerk; Marc D Cohen; Bernard Combe; Karen H Costenbader; Maxime Dougados; Paul Emery; Gianfranco Ferraccioli; Johanna M W Hazes; Kathryn Hobbs; Tom W J Huizinga; Arthur Kavanaugh; Jonathan Kay; Tore K Kvien; Timothy Laing; Philip Mease; Henri A Ménard; Larry W Moreland; Raymond L Naden; Theodore Pincus; Josef S Smolen; Ewa Stanislawska-Biernat; Deborah Symmons; Paul P Tak; Katherine S Upchurch; Jirí Vencovský; Frederick Wolfe; Gillian Hawker
Journal:  Arthritis Rheum       Date:  2010-09

6.  The safety and efficacy of a JAK inhibitor in patients with active rheumatoid arthritis: Results of a double-blind, placebo-controlled phase IIa trial of three dosage levels of CP-690,550 versus placebo.

Authors:  Joel M Kremer; Bradley J Bloom; Ferdinand C Breedveld; John H Coombs; Mark P Fletcher; David Gruben; Sriram Krishnaswami; Rubén Burgos-Vargas; Bethanie Wilkinson; Cristiano A F Zerbini; Samuel H Zwillich
Journal:  Arthritis Rheum       Date:  2009-07

7.  Gut-residing segmented filamentous bacteria drive autoimmune arthritis via T helper 17 cells.

Authors:  Hsin-Jung Wu; Ivaylo I Ivanov; Jaime Darce; Kimie Hattori; Tatsuichiro Shima; Yoshinori Umesaki; Dan R Littman; Christophe Benoist; Diane Mathis
Journal:  Immunity       Date:  2010-06-25       Impact factor: 31.745

8.  The Stop Arthritis Very Early (SAVE) trial, an international multicentre, randomised, double-blind, placebo-controlled trial on glucocorticoids in very early arthritis.

Authors:  Klaus P Machold; Robert Landewé; Josef S Smolen; Tanja A Stamm; Désirée M van der Heijde; Kirsten N Verpoort; Kerstin Brickmann; Janitzia Vázquez-Mellado; Dimitri E Karateev; Ferdinand C Breedveld; Paul Emery; Thomas W J Huizinga
Journal:  Ann Rheum Dis       Date:  2010-03       Impact factor: 19.103

9.  Beneficial effects of a 3-week course of intramuscular glucocorticoid injections in patients with very early inflammatory polyarthritis: results of the STIVEA trial.

Authors:  S M M Verstappen; M J McCoy; C Roberts; N E Dale; A B Hassell; D P M Symmons
Journal:  Ann Rheum Dis       Date:  2009-10-12       Impact factor: 19.103

10.  Prognostic factors in a large cohort of patients with early undifferentiated inflammatory arthritis after application of a structured management protocol.

Authors:  Mark A Quinn; Michael J Green; Helena Marzo-Ortega; Susanna Proudman; Zunaid Karim; Richard J Wakefield; Philip G Conaghan; Paul Emery
Journal:  Arthritis Rheum       Date:  2003-11
  10 in total
  8 in total

1.  Inhibition of antigen trafficking through scavenger receptor A.

Authors:  Maurice T Raycroft; Bohdan P Harvey; Matthew J Bruck; Mark J Mamula
Journal:  J Biol Chem       Date:  2012-01-03       Impact factor: 5.157

2.  Gene profiling of Chikungunya virus arthritis in a mouse model reveals significant overlap with rheumatoid arthritis.

Authors:  Helder I Nakaya; Joy Gardner; Yee-Suan Poo; Lee Major; Bali Pulendran; Andreas Suhrbier
Journal:  Arthritis Rheum       Date:  2012-11

3.  Fostamatinib, an oral spleen tyrosine kinase inhibitor, in the treatment of rheumatoid arthritis: a meta-analysis of randomized controlled trials.

Authors:  Sumit Kunwar; Ashok Raj Devkota; Dipesh K C Ghimire
Journal:  Rheumatol Int       Date:  2016-04-25       Impact factor: 2.631

4.  A reversible gene trap collection empowers haploid genetics in human cells.

Authors:  Tilmann Bürckstümmer; Carina Banning; Philipp Hainzl; Richard Schobesberger; Claudia Kerzendorfer; Florian M Pauler; Doris Chen; Nicole Them; Fiorella Schischlik; Manuele Rebsamen; Michal Smida; Ferran Fece de la Cruz; Ana Lapao; Melissa Liszt; Benjamin Eizinger; Philipp M Guenzl; Vincent A Blomen; Tomasz Konopka; Bianca Gapp; Katja Parapatics; Barbara Maier; Johannes Stöckl; Wolfgang Fischl; Sejla Salic; M Rita Taba Casari; Sylvia Knapp; Keiryn L Bennett; Christoph Bock; Jacques Colinge; Robert Kralovics; Gustav Ammerer; Georg Casari; Thijn R Brummelkamp; Giulio Superti-Furga; Sebastian M B Nijman
Journal:  Nat Methods       Date:  2013-08-25       Impact factor: 28.547

Review 5.  Using EAE to better understand principles of immune function and autoimmune pathology.

Authors:  Manu Rangachari; Vijay K Kuchroo
Journal:  J Autoimmun       Date:  2013-07-09       Impact factor: 7.094

6.  A transient peak of infections during onset of rheumatoid arthritis: a 10-year prospective cohort study.

Authors:  Marina I Arleevskaya; Aida G Gabdoulkhakova; Yulia V Filina; Regina R Miftakhova; Anders Bredberg; Anatoly P Tsybulkin
Journal:  BMJ Open       Date:  2014-09-01       Impact factor: 2.692

7.  Contribution of bacterial pathogens to evoking serological disease markers and aggravating disease activity in rheumatoid arthritis.

Authors:  Kuniaki Terato; Takaki Waritani; Richio Fukai; Hiroshi Shionoya; Hiroshi Itoh; Kou Katayama
Journal:  PLoS One       Date:  2018-02-06       Impact factor: 3.240

8.  Oral and Intestinal Bacterial Substances Associated with Disease Activities in Patients with Rheumatoid Arthritis: A Cross-Sectional Clinical Study.

Authors:  Kaori Kitamura; Hiroshi Shionoya; Suguru Suzuki; Richio Fukai; Shinichi Uda; Chiyuki Abe; Hiromitsu Takemori; Keita Nishimura; Hisashi Baba; Kou Katayama; Kuniaki Terato; Takaki Waritani
Journal:  J Immunol Res       Date:  2022-02-18       Impact factor: 4.818
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.